Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.
McMahon M, O'Dell G, Tan J, Sárközy A, Vadovics M, Carreño JM, Puente-Massaguer E, Muramatsu H, Bajusz C, Rijnink W, Beattie M, Tam YK, Kirkpatrick Roubidoux E, Francisco I, Strohmeier S, Kanekiyo M, Graham BS, Krammer F, Pardi N.
McMahon M, et al. Among authors: francisco i.
Proc Natl Acad Sci U S A. 2022 Nov 8;119(45):e2206333119. doi: 10.1073/pnas.2206333119. Epub 2022 Nov 2.
Proc Natl Acad Sci U S A. 2022.
PMID: 36322769
Free PMC article.